“Novo Nordisk heard loud and clear the impact to the 15,000 Australians living with diabetes who depended on FIASP, if FIASP was no longer available on the PBS. We are pleased that patients can continue accessing this treatment on the PBS,” said Cem Ozenc, corporate vice president and general manager of Novo Nordisk Oceania. …
Patients win reprieve with Novo Nordisk listing a new form of insulin aspart
September 17, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The 'Dispatched' Podcast - Series 5. Ep.29
August 21, 2026 - - Podcast -
IDT Australia targets profitability after reporting sharply narrowing loss
August 21, 2026 - - Latest News -
Opportunity #5 - From the hardest thing to secure to the easiest thing to get right
August 21, 2026 - - Latest News -
Biogen bolsters leadership ranks as it sharpens focus on patient access and innovation
August 21, 2026 - - Latest News -
Advent moves to acquire majority stake in NZCR Group
August 21, 2026 - -
Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma
August 21, 2026 - - Latest News -
New Zealand researchers honoured for work tackling superbugs and blood cancer
August 20, 2026 - - Latest News